245 related articles for article (PubMed ID: 20501981)
1. Factor V is an anticoagulant cofactor for activated protein C during inactivation of factor Va.
Cramer TJ; Griffin JH; Gale AJ
Pathophysiol Haemost Thromb; 2010; 37(1):17-23. PubMed ID: 20501981
[TBL] [Abstract][Full Text] [Related]
2. Identification and functional characterization of a novel F5 mutation (Ala512Val, FVB onn ) associated with activated protein C resistance.
Pezeshkpoor B; Castoldi E; Mahler A; Hanel D; Müller J; Hamedani NS; Biswas A; Oldenburg J; Pavlova A
J Thromb Haemost; 2016 Jul; 14(7):1353-63. PubMed ID: 27090446
[TBL] [Abstract][Full Text] [Related]
3. The C-terminal region of the factor V B-domain is crucial for the anticoagulant activity of factor V.
Thorelli E; Kaufman RJ; Dahlbäck B
J Biol Chem; 1998 Jun; 273(26):16140-5. PubMed ID: 9632668
[TBL] [Abstract][Full Text] [Related]
4. Comparison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V.
Lu D; Kalafatis M; Mann KG; Long GL
Blood; 1996 Jun; 87(11):4708-17. PubMed ID: 8639840
[TBL] [Abstract][Full Text] [Related]
5. Factor V and thrombotic disease: description of a janus-faced protein.
Nicolaes GA; Dahlbäck B
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):530-8. PubMed ID: 11950687
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V.
Thorelli E; Kaufman RJ; Dahlbäck B
Blood; 1999 Apr; 93(8):2552-8. PubMed ID: 10194434
[TBL] [Abstract][Full Text] [Related]
7. The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa.
Evenäs P; García de Frutos P; Nicolaes GA; Dahlbäck B
Thromb Haemost; 2000 Aug; 84(2):271-7. PubMed ID: 10959700
[TBL] [Abstract][Full Text] [Related]
8. Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations.
Castoldi E; Brugge JM; Nicolaes GA; Girelli D; Tans G; Rosing J
Blood; 2004 Jun; 103(11):4173-9. PubMed ID: 14976057
[TBL] [Abstract][Full Text] [Related]
9. Emicizumab-mediated haemostatic function in patients with haemophilia A is down-regulated by activated protein C through inactivation of activated factor V.
Yada K; Nogami K; Shinozawa K; Kitazawa T; Hattori K; Amano K; Fukutake K; Shima M
Br J Haematol; 2018 Oct; 183(2):257-266. PubMed ID: 30125997
[TBL] [Abstract][Full Text] [Related]
10. The SHBG-like region of protein S is crucial for factor V-dependent APC-cofactor function.
Nyberg P; Dahlbäck B; García de Frutos P
FEBS Lett; 1998 Aug; 433(1-2):28-32. PubMed ID: 9738926
[TBL] [Abstract][Full Text] [Related]
11. The anticoagulant function of coagulation factor V.
Cramer TJ; Gale AJ
Thromb Haemost; 2012 Jan; 107(1):15-21. PubMed ID: 22116556
[TBL] [Abstract][Full Text] [Related]
12. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of recombinant FV Hong Kong and FV Cambridge.
Norstrøm E; Thorelli E; Dahlbäck B
Blood; 2002 Jul; 100(2):524-30. PubMed ID: 12091344
[TBL] [Abstract][Full Text] [Related]
14. Functional properties of factor V and factor Va encoded by the R2-gene.
Hoekema L; Castoldi E; Tans G; Girelli D; Gemmati D; Bernardi F; Rosing J
Thromb Haemost; 2001 Jan; 85(1):75-81. PubMed ID: 11204592
[TBL] [Abstract][Full Text] [Related]
15. Regulation of factor V by the anticoagulant protease activated protein C: Influence of the B-domain and TFPIα.
Ayombil F; Petrillo T; Kim H; Camire RM
J Biol Chem; 2022 Nov; 298(11):102558. PubMed ID: 36183835
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene.
Aparicio C; Dahlbäck B
Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):467-72. PubMed ID: 8573079
[TBL] [Abstract][Full Text] [Related]
17. Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies interfere with cleavage of factor V(a) by activated protein C.
Noordermeer T; Chemlal S; Jansma JJ; van der Vegte V; Schutgens REG; Limper M; de Groot PG; Meijers JCM; Urbanus RT
J Thromb Haemost; 2023 Sep; 21(9):2509-2518. PubMed ID: 37290588
[TBL] [Abstract][Full Text] [Related]
18. Carbohydrate moieties on the procofactor factor V, but not the derived cofactor factor Va, regulate its inactivation by activated protein C.
Silveira JR; Kalafatis M; Tracy PB
Biochemistry; 2002 Feb; 41(5):1672-80. PubMed ID: 11814362
[TBL] [Abstract][Full Text] [Related]
19. The roles of factor Va and protein S in formation of the activated protein C/protein S/factor Va inactivation complex.
Gierula M; Salles-Crawley II; Santamaria S; Teraz-Orosz A; Crawley JTB; Lane DA; Ahnström J
J Thromb Haemost; 2019 Dec; 17(12):2056-2068. PubMed ID: 31364267
[TBL] [Abstract][Full Text] [Related]
20. Prothrombin amino terminal region helps protect coagulation factor Va from proteolytic inactivation by activated protein C.
Yegneswaran S; Nguyen PM; Gale AJ; Griffin JH
Thromb Haemost; 2009 Jan; 101(1):55-61. PubMed ID: 19132189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
